These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23436584)

  • 41. Residual neck disease management in squamous-cell carcinoma of the head and neck treated with radiotherapy plus cetuximab.
    Montal R; Oliva M; Taberna M; De Avila L; Rovira A; Cos M; Mañós M; Navarro V; Nogués J; Lozano A; Rodríguez L; Vilajosana E; Vázquez S; Mesia R
    Clin Transl Oncol; 2016 Nov; 18(11):1140-1146. PubMed ID: 26960559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term results of positron emission tomography-directed management of the neck in node-positive head and neck cancer after organ preservation therapy.
    Sjövall J; Chua B; Pryor D; Burmeister E; Foote MC; Panizza B; Burmeister BH; Porceddu SV
    Oral Oncol; 2015 Mar; 51(3):260-6. PubMed ID: 25553622
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lessons from a standardized program using PET-CT to avoid neck dissection after primary radiotherapy for N2 squamous cell carcinoma of the oropharynx.
    Hitchcock KE; Amdur RJ; Mendenhall WM; Werning JW; Drane WE; Mancuso AA
    Oral Oncol; 2015 Sep; 51(9):870-4. PubMed ID: 26164415
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is there an additive value of 18 F-FDG PET-CT to CT/MRI for detecting nodal metastasis in oropharyngeal squamous cell carcinoma patients with palpably negative neck?
    Sohn B; Koh YW; Kang WJ; Lee JH; Shin NY; Kim J
    Acta Radiol; 2016 Nov; 57(11):1352-1359. PubMed ID: 26013025
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Posttreatment surveillance PET/CT for HPV-associated oropharyngeal cancer.
    Corpman DW; Masroor F; Carpenter DM; Nayak S; Gurushanthaiah D; Wang KH
    Head Neck; 2019 Feb; 41(2):456-462. PubMed ID: 30549345
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapy Response Assessment and Patient Outcomes in Head and Neck Squamous Cell Carcinoma: FDG PET Hopkins Criteria Versus Residual Neck Node Size and Morphologic Features.
    Wray R; Sheikhbahaei S; Marcus C; Zan E; Ferraro R; Rahmim A; Subramaniam RM
    AJR Am J Roentgenol; 2016 Sep; 207(3):641-7. PubMed ID: 27341273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Positron emission tomography-computed tomography surveillance for the node-positive neck after chemoradiotherapy.
    Rabalais AG; Walvekar R; Nuss D; McWhorter A; Wood C; Fields R; Mercante DE; Pou AM
    Laryngoscope; 2009 Jun; 119(6):1120-4. PubMed ID: 19358193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial.
    Weinstein GS; Quon H; O'Malley BW; Kim GG; Cohen MA
    Laryngoscope; 2010 Sep; 120(9):1749-55. PubMed ID: 20717944
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Positron emission tomography in combination with sentinel node biopsy reduces the rate of elective neck dissections in the treatment of oral and oropharyngeal cancer.
    Kovács AF; Döbert N; Gaa J; Menzel C; Bitter K
    J Clin Oncol; 2004 Oct; 22(19):3973-80. PubMed ID: 15459220
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changing trends in the management of the neck in oropharyngeal squamous cell carcinoma.
    Jouhi L; Atula T; Saarilahti K; Hagström J; Haglund C; Mohamed H; Mäkitie A; Keski-Säntti H
    Head Neck; 2017 Jul; 39(7):1412-1420. PubMed ID: 28464452
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma.
    Kim SY; Kim JS; Yi JS; Lee JH; Choi SH; Nam SY; Cho KJ; Lee SW; Kim SB; Roh JL
    Ann Surg Oncol; 2011 Sep; 18(9):2579-84. PubMed ID: 21409485
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study.
    Taghipour M; Mena E; Kruse MJ; Sheikhbahaei S; Subramaniam RM
    Nucl Med Commun; 2017 Mar; 38(3):250-258. PubMed ID: 28099264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction chemotherapy followed by concurrent chemoradiation versus concurrent chemoradiation alone in the definitive management of p16-positive oropharyngeal squamous cell carcinoma with low-neck or N3 disease.
    Bhattasali O; Han J; Thompson LDR; Buchschacher GL; Abdalla IA; Iganej S
    Oral Oncol; 2018 Mar; 78():151-155. PubMed ID: 29496043
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exploration for an Algorithm for Deintensification to Exclude the Retropharyngeal Site From Advanced Oropharyngeal Squamous Cell Carcinoma Treatment.
    Spector ME; Chinn SB; Bellile E; Gallagher KK; Kang SY; Moyer JS; Prince ME; Wolf GT; Bradford CR; McHugh JB; Carey TE; Worden FP; Eisbruch A; Ibrahim M; Chepeha DB
    JAMA Otolaryngol Head Neck Surg; 2016 Apr; 142(4):313-8. PubMed ID: 26892642
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Imaging strategy for response evaluation to chemoradiotherapy of the nodal disease in patients with head and neck squamous cell carcinoma.
    Nishimura G; Yabuki K; Hata M; Komatsu M; Taguchi T; Takahashi M; Shiono O; Sano D; Arai Y; Takahashi H; Chiba Y; Oridate N
    Int J Clin Oncol; 2016 Aug; 21(4):658-667. PubMed ID: 26710795
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Subramaniam RM; DeMora L; Yao M; Yom SS; Gillison M; Caudell JJ; Waldron J; Xia P; Chung CH; Truong MT; Echevarria M; Chan JW; Geiger JL; Mell L; Seaward S; Thorstad WL; Beitler JJ; Sultanem K; Blakaj D; Le QT
    J Nucl Med; 2023 Mar; 64(3):362-367. PubMed ID: 36215572
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Survival outcomes in patients with oropharyngeal cancer treated with carboplatin/paclitaxel and concurrent radiotherapy.
    Roskies M; Kay-Rivest E; Mascarella MA; Sultanem K; Mlynarek A; Hier M
    J Otolaryngol Head Neck Surg; 2016 Oct; 45(1):50. PubMed ID: 27724969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment response in the neck: p16+ versus p16- oropharyngeal cancer.
    Mak D; Hicks RJ; Rischin D; Solomon B; Peters L; Bressel M; Young RJ; Corry J
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):364-72. PubMed ID: 23721148
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PET-CT vs contrast-enhanced CT: what is the role for each after chemoradiation for advanced oropharyngeal cancer?
    Chen AY; Vilaseca I; Hudgins PA; Schuster D; Halkar R
    Head Neck; 2006 Jun; 28(6):487-95. PubMed ID: 16619274
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic value of pretreatment ¹⁸F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma.
    Cheng NM; Chang JT; Huang CG; Tsan DL; Ng SH; Wang HM; Liao CT; Lin CY; Hsu CL; Yen TC
    Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1673-84. PubMed ID: 22854984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.